Financial

Cardiovascular Systems, Inc. Acquires Gardia Medical Ltd.’s WIRION™ Embolic Protection System

ST. PAUL, Minn.–(BUSINESS WIRE)–Cardiovascular Systems, Inc. (CSI®) (NASDAQ: CSII), a medical device company developing and commercializing innovative interventional treatment systems for patients with peripheral and coronary artery disease, announced today that it has acquired the WIRION Embolic Protection System and related assets from Gardia Medical Ltd., a wholly owned Israeli […]

BioVentrix Announces Key Additions to Leadership Team

SAN RAMON, Calif., Aug. 6, 2019 /PRNewswire/ — BioVentrix, Inc., a pioneer of technologies and procedures for the less invasive treatment of heart failure (HF), today announced two significant additions to its executive team. Thasee Pillay, MBChB has been named Chief Medical Officer for Europe and William Abbott has been named Chief Financial Officer. “The appointments of […]

CeloNova Announces Appointment of New President and CEO

SAN ANTONIO, Texas, Aug. 6, 2019 /PRNewswire/ — CeloNova BioSciences, Inc. (CeloNova), a global medical device company and manufacturer of the proprietary Polyzene™-F nanocoating technology, currently used to surface coat its novel COBRA PzF NanoCoated Coronary Stent (NCS), today announced appointment of seasoned medical device executive Carl J. St. Bernard as President and Chief Executive Officer […]

Quanterix Corporation Releases Operating Results for Second Quarter 2019

BILLERICA, Mass.–(BUSINESS WIRE)–Quanterix Corporation (NASDAQ: QTRX), a company digitizing biomarker analysis to advance the science of precision health, today announced financial results for the three and six months ended June 30, 2019. “We are pleased with our execution and yet another quarter of record results, with strong revenue growth and […]

BioCardia Announces Pricing of $10.0 Million Public Offering and Uplisting to Nasdaq

SAN CARLOS, Calif., Aug. 02, 2019 (GLOBE NEWSWIRE) — BioCardia, Inc. (NasdaqCM: BCDA, BCDAW), a leader in the development of comprehensive solutions for cardiovascular regenerative therapies, today announced the pricing of its public offering of 1,666,667 units at a price to the public of $6.00 per unit. Each unit issued in the […]

Avinger Reports 26% Sequential Revenue Growth in Second Quarter 2019

Revenue Growth Fuels Strong Operating Metrics Pantheris SV Limited Launch at Key U.S. Sites in July REDWOOD CITY, Calif., July 31, 2019 (GLOBE NEWSWIRE) — Avinger, Inc. (Nasdaq: AVGR), a commercial-stage medical device company marketing the first and only intravascular image-guided, catheter-based system for diagnosis and treatment of patients with […]

Leviticus Cardio Appoints Prof. Nir Uriel to its Scientific Advisory Board

PETAH-TIKVA, Israel, Aug. 1, 2019 /PRNewswire/ — Leviticus Cardio today announced the appointment of Prof. Nir Urielto its Scientific Advisory Board. “We are very excited that Prof. Uriel has joined our Scientific Advisory Board. He is a leader in the field of heart failure, mechanical circulatory support and heart transplantation, and he will help us greatly in promoting our […]